Follow-up Study to Assess Safety and Clinical Activity of Continued AFFITOPE® AD02 Vaccinations of Patients Who Participated in AFF006
Stopped Study AFF006A was early terminated by the sponsor based on the results of study AFF006.
Conditions
Interventions
- BIOLOGICAL: AFFITOPE® AD02
- BIOLOGICAL: Placebo
Sponsor
Affiris AG